EP3060303
MRNA THERAPY FOR ARGININOSUCCINATE SYNTHETASE DEFICIENCY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.10.2014EP published:
14.11.2018EP application number:
14799919.7
EPO information:
European Patent Register
Max expiry date:
21.10.2034
Title:
MRNA THERAPY FOR ARGININOSUCCINATE SYNTHETASE DEFICIENCY
Timeline
Today
22.10.2014EP application
14.11.2018EP Publication
Owner
Name:
Translate Bio, Inc.Address:
29 Hartwell Avenue, 02421, Lexington, MA, US
Inventor
Name:
HEARTLEIN, MichaelAddress:
Lexington, Massachusetts, US
Name:
DEROSA, FrankAddress:
Lexington, Massachusetts, US
Name:
SMITH, LianneAddress:
Lexington, Massachusetts, US
Priority
Number:
201361894294 PDate:
22.10.2013Country:
US
Classification
Categories:
A61P 3/00, A61K 9/127, A61K 48/00, A61K 31/7105